SCHEMBL18216643

SCHEMBL18216643

CC(=O)N1CCNC(=O)NC(=O)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.42
CRBN Q96SW2 2/20 0.41
TSHR P16473 1/20 0.40
TDP1 Q9NUW8 2/20 0.38
POLB P06746 1/20 0.38
TOP2A P11388 1/20 0.38
TOP2B Q02880 1/20 0.38
PKM P14618 1/20 0.37
HSP90AA1 P07900 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NOTUM Q6P988 2/20 0.35
GFER P55789 1/20 0.34
GAA P10253 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
ALDH1A1 P00352 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RAB9A P51151 2/20 0.33
PARP1 P09874 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3907606 0.85 KMT2A (0.56) KMT2ATSHRTDP1POLBTOP2A
SCHEMBL791534 0.76 PKM (0.50) KMT2ACRBNTSHRTDP1TOP2A
SCHEMBL16751026 0.72 KMT2A (0.42) KMT2ACRBNTSHRTDP1POLB
SCHEMBL163317 0.67 KMT2A (0.58) KMT2ATSHRTDP1POLBTOP2A
SCHEMBL14001959 0.66 KMT2A (0.56) KMT2ATSHRTDP1POLBTOP2A
SCHEMBL5005151 0.66 KMT2A (0.56) KMT2ATSHRTDP1POLBTOP2A
SCHEMBL28838729 0.66 KMT2A (0.56) KMT2ATSHRTDP1POLBTOP2A
SCHEMBL22098107 0.66 KMT2A (0.34) KMT2ATSHRTDP1NOTUMLMNA
SCHEMBL24536147 0.66 CRBN (0.42) CRBNTDP1POLBTOP2ATOP2B
SCHEMBL12233461 0.66 TSHR (0.63) KMT2ATSHRTDP1POLBTOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9771320-B2 Carbocyclic sulfone RORγ modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2017-09-26 US disclosed
US-20160326103-A1 CARBOCYCLIC SULFONE ROR GAMMA MODULATORS BRISTROL-MYERS SQUIBB COMPANY (US) 2016-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160326103-A1 CARBOCYCLIC SULFONE ROR GAMMA MODULATORS RORC, RORB, RORA KMT2A 2551/4885CRBN 547/4885TSHR 370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.